191 related articles for article (PubMed ID: 28029283)
1. Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.
Witter LE; Gruber EJ; Lean FZ; Stokol T
Am J Vet Res; 2017 Jan; 78(1):69-79. PubMed ID: 28029283
[TBL] [Abstract][Full Text] [Related]
2. Role of tissue factor expression in thrombin generation by canine tumor cells.
Gruber EJ; Catalfamo JL; Stokol T
Am J Vet Res; 2016 Apr; 77(4):404-12. PubMed ID: 27027841
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor procoagulant activity in the tumor cell lines and plasma of dogs with various malignant tumors.
Kobayashi K; Baba K; Igase M; Primarizky H; Nemoto Y; Shimokawa Miyama T; Kambayashi S; Mizuno T; Okuda M
J Vet Med Sci; 2019 Dec; 81(12):1713-1721. PubMed ID: 31611484
[TBL] [Abstract][Full Text] [Related]
4. Canine splenic hemangiosarcoma cells express and activate luteinizing hormone receptors in vitro.
Zwida KH; Kutzler MA
Am J Vet Res; 2022 Nov; 83(12):. PubMed ID: 36327166
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
6. Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
Rodriguez AM; Graef AJ; LeVine DN; Cohen IR; Modiano JF; Kim JH
J Vet Intern Med; 2015; 29(4):1088-97. PubMed ID: 26118793
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
9. Hyperferritinemia in dogs with splenic hemangiosarcoma.
Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N; Higuchi S
J Vet Med Sci; 2013 Nov; 75(11):1515-8. PubMed ID: 23803459
[TBL] [Abstract][Full Text] [Related]
10. Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma.
Im KS; Graef AJ; Breen M; Lindblad-Toh K; Modiano JF; Kim JH
Vet Comp Oncol; 2017 Jun; 15(2):315-327. PubMed ID: 26337509
[TBL] [Abstract][Full Text] [Related]
11. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
[TBL] [Abstract][Full Text] [Related]
12. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.
Thamm DH; Dickerson EB; Akhtar N; Lewis R; Auerbach R; Helfand SC; MacEwen EG
Res Vet Sci; 2006 Aug; 81(1):76-86. PubMed ID: 16256156
[TBL] [Abstract][Full Text] [Related]
13. Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages.
Gulay KCM; Aoshima K; Maekawa N; Suzuki T; Konnai S; Kobayashi A; Kimura T
Sci Rep; 2022 Feb; 12(1):2124. PubMed ID: 35136176
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study.
von Beust BR; Suter MM; Summers BA
Vet Pathol; 1988 Jul; 25(4):251-5. PubMed ID: 3136585
[TBL] [Abstract][Full Text] [Related]
15. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
[TBL] [Abstract][Full Text] [Related]
16. Treatment of canine hemangiosarcoma: 2000 and beyond.
Clifford CA; Mackin AJ; Henry CJ
J Vet Intern Med; 2000; 14(5):479-85. PubMed ID: 11012108
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
Pyuen AA; Meuten T; Rose BJ; Thamm DH
PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
[TBL] [Abstract][Full Text] [Related]
20. Hemangiosarcoma in a dog.
Slaughter LJ; Herman L
J Am Vet Med Assoc; 1969 Jan; 154(1):17-21. PubMed ID: 5812449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
